IL6 and metabolic syndrome: We found that Amuc_1100 intervention significantly reduced the mRNA levels of Il6 in 3T3-L1 cells (Fig. S1 in the supplemental material), demonstrating that Amuc_1100 inhibits inflammation-associated lipolysis and indicating that Amuc_1100 protects the body from metabolic syndromes and has less adverse effects.